Feedback
Contact
Calendar
Employment
RFP
Français
myGAVI
RSS & Follow
Lowband
Home
About the Alliance
Learn more about GAVI
GAVI's mission
What we do
GAVI's impact
Challenges and opportunities
Gender and immunisation
Why invest in GAVI?
Advocates
GAVI's strategy
Value of vaccination
GAVI's partnership model
GAVI's business model
Global health and development
Governing GAVI
GAVI Board
GAVI Secretariat
GAVI Internal Audit
Finance & Programmatic policies
Types of support
What GAVI offers and how it works
Apply for support
New and underused vaccines support
Hepatitis B vaccine
Hib vaccine
Human papillomavirus vaccine
Injection safety support
Measles second dose
Meningitis A vaccine
Pneumococcal vaccine
Rubella vaccine
Rotavirus vaccine
Yellow fever vaccine
Immunisation services support
Health Systems Funding Platform
Health system strengthening
Civil society organisation
Country hub
Afghanistan
Albania
Angola
Armenia
Azerbaijan
Bangladesh
Benin
Bhutan
Bolivia
Bosnia & Herzegovina
Burkina Faso
Burundi
Cambodia
Cameroon
Central African Republic (the)
Chad
China
Comoros
Congo
Congo, DR
Côte d’Ivoire
Cuba
Djibouti
Eritrea
Ethiopia
Gambia
Georgia
Ghana
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
India
Indonesia
Kenya
Kiribati
Korea, DPR
Kyrgyzstan
Lao PDR
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Moldova
Mongolia
Mozambique
Myanmar
Nepal
Nicaragua
Niger
Nigeria
Pakistan
Papua New Guinea
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
Solomon Islands
Somalia
South Sudan
Sri Lanka
Sudan
Tajikistan
Tanzania, UR
Timor Leste
Togo
Turkmenistan
Uganda
Ukraine
Uzbekistan
Vietnam
Yemen
Zambia
Zimbabwe
Funding & finance
Long-term financial commitments
Save lives, give to GAVI
How GAVI is funded
Key figures: donor contributions & pledges
Donor profiles
Resource mobilisation
GAVI’s resource mobilisation process
GAVI's funding challenge
Financial reports
Pneumococcal AMC
Results & evidence
Measuring & evaluating performance
Goal-level indicators
Mission indicators
Vaccine goal indicators
Health systems goal indicators
Financing goal indicators
Market-shaping goal indicators
Countries approved for support
Disbursements by country
GAVI's evaluation studies
GAVI first evaluation report
GAVI second evaluation report
International Finance Facility for Immunisation evaluation
Other studies
GAVI Progress reports
Library & news
Search by topic, country and programme
News
Press releases
Statements
Return on investment stories
GAVI features
GAVI blogs
Audio-visual
Board & committee minutes
GAVI documents
Country documents
Evaluations
Financial reports
Guidelines and forms
Policies
Strategy
Supply and procurement
Publications
Events
You are here:
Library
Audio-visual
Audio-visual
Galleries
Galleries
Investing in the lives of world's poorest children
Investing in the lives of world's poorest children
in page functions
Pioneered in 2006, the International Finance Facility for Immunisation (IFFIm) builds a financial lifeline from the world's richest investors to its poorest children.
IFFIm converts government pledges into immediately available funding for GAVI by issuing 'vaccine bonds' in capital markets. 'Predictable', secure support encourages developing countries to invest in long-term immunisation programmes.
Jay Louvion/GAVI/08
Under the leadership of IFFIm Board chairman Alan Gillespie, IFFIm has attracted US$ 6.2 billion in donor commitments over 23 years. IFFIm provides a flexible funding alternative for donors, especially those that are not able to provide large direct grants.
Photographic Service L'Osservatore Romano/09
Former UK Premier Gordon Brown, who helped pioneer IFFIm, visits Pope Benedict XVI to commemorate the Vatican’s purchase of the first vaccine bond in 2006. IFFIm has raised US$ 3.2 billion in bond sales in the UK, Japan and Australia.
Dan Thomas/GAVI/09
With a triple-A rating, IFFIm promises investors like Keiko Aoshima a solid return. “With other bonds, you never really know how your money will be used, but this investment will be used for human good."
Dominic Chavez/GAVI/08
Thanks to IFFIm funds, GAVI has effectively doubled its spending on immunisation and health system strengthening programmes since 2006.
Edy Purnomo/GAVI/07
IFFIm’s long-term funding acts as an incentive for the vaccine industry to invest the large sums of money necessary to develop and manufacture appropriate vaccines for poorer countries.
Olivier Asselin/GAVI/08
It also gives Health Ministries in developing countries confidence to make long-term investments in immunisation programmes, such as strengthening vaccine delivery systems or training health workers.
Olivier Asselin/GAVI/08
Mothers at the Barumbu Mother & Child Centre in Kinshasa in DR Congo discuss immunisation with a health worker. In 2007, GAVI channelled US$ 88.3 million of IFFIm funds into strengthening health systems.
Olivier Asselin/GAVI/09
The availability of IFFIm funds to support the introduction of the five-in-one pentavalent vaccine until 2015 is encouraging new manufacturers to enter the market.
Olivier Asselin/WHO/08
A young boy is vaccinated against yellow fever in Togo, one of 1.3 million people targeted in an emergency immunisation campaign. In 2007, IFFIm funds helped build up a regional stockpile of yellow fever vaccine for west African countries.
Olivier Asselin/GAVI/09
The IFFIm model has "successfully demonstrated a proof of concept, proven to be financially efficient ... achieved supranational status in the capital markets." Independent evaluation of IFFIm, June 2011.
Share this gallery
Latest Galleries
The human tragedy and the hope behind Ghana’s historic decision
Model immunisation system sets standard for Mozambique
Seth Berkley in Mozambique March 2012
Chad’s campaign against meningitis A
GAVI’s Matching Fund announcement at WEF
Laos' efforts to stop rubella and measles for good
The toll of cervical cancer
Civil society in Bangladesh
Immunisation in Bangladesh
Pneumococcal vaccines introduced in Malawi
View all latest galleries
Related Library items
International Finance Facility for Immunisation issues inaugural bonds
Immunisation week highlights progress and challenges ahead
Key European nations join UK and France to commit nearly US$4 billion to expand child immunisation in developing countries
GAVI Alliance programme raises US$ 38 million for child immunisation
Study shows better health buys long-term wealth in developing countries
Related information
What we do
Private sector engagement crucial for improving women’s and children’s health
Japanese investors continue to show strong interest in IFFIm
GAVI pledging conference June 2011
Investing in health yields financial returns and benefits developing countries
Search keywords
IFFIm
vaccine bonds
funding
innovative financing
modal window here